Company Financials

Genesis Healthcare Inc. Financials

United States dollar

business Genesis Healthcare Inc. Company Profile

Main Stock Listing

NYSE: GEN

Market Capitalization $16.08 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 29.88
Forward PE 9.52
Price to Sales TTM $3.75
Price to Book MRQ $6.83
Enterprise to Revenue 5.56
Enterprise to EBITDA 12.78

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2025-03-28
Most Recent Quarter 2025-09-30
Profit Margin 12.74%
Operating Margin 36.48%
Return on Assets TTM 6.86%
Return on Equity TTM 25.03%

Income Statement

Revenue TTM $4,472,999,936
Revenue per Share TTM $7.26
Quarterly Revenue Growth 25.30%
Gross Profit TTM $3,548,000,000
EBITDA $2,181,000,000
Net Income to Common TTM $570,000,000
Diluted EPS TTM $0.91
Quarterly Earnings Growth YoY -16.80%

Balance Sheet

Total Cash MRQ $691,000,000
Total Cash per Share MRQ $1.12
Total Debt MRQ $
Total Debt to Equity MRQ 356.98
Current Ratio MRQ 0.51
Book Value per Share MRQ $3.98

Cash Flow

Operating Cash Flow TTM $1,324,000,000
Levered Free Cash Flow TTM $1,076,625,024

GEN Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 617,000,000
Float Shares 472,379,869
Avg 10 Volume 5,627,510
Avg 30 Volume None
Shares Short 18,696,893
Short Ratio 4.26
Short % of Shares 3.82%
% Held by Insiders 9.31%
% Held by Institutions 88.11%

Stock Price Summary

Beta 1.11
Fifty Two Week Low $22.74
Fifty Two Week High $32.22
Fifty Two Week Change -5.22%
Day 50 MA $26.84
Day 200 MA $28.03

Dividends and Splits

Forward Annual Dividend Rate $0.50
Forward Annual Dividend Yield 1.92%
Trailing Annual Dividend Rate $0.50
Trailing Annual Dividend Yield 1.92%
Payout Ratio 54.95%
Dividend Date 2025-12-10
Ex Dividend Date 2025-11-17
Last Split Factor
Last Split Date 2004-12-01